bosentan anhydrous has been researched along with Patency of the Ductus Arteriosus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, Y; He, J; Ren, Y | 1 |
| Bull, DA; Hatton, N; Ryan, JJ; Suksaranjit, P; Wilson, BD | 1 |
| Feng, Y; Ling, Y; Mei, F; Wang, Y | 1 |
| Bilici, M; Guzeltas, A; Odemis, E; Özyılmaz, İ; Tanidir, IC | 1 |
| Aiello, R; Caruso, E; Mulè, M; Tamburino, C; Ussia, GP | 1 |
| Anagnostopoulos, CE; Apostolopoulou, SC; Kanakis, MA; Mitropoulos, FA; Rammos, S | 1 |
6 other study(ies) available for bosentan anhydrous and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Bosentan treatment for pulmonary arterial hypertension due to patent ductus arteriosus and Down's syndrome in an infant.
Topics: Antihypertensive Agents; Bosentan; Down Syndrome; Ductus Arteriosus, Patent; Humans; Hypertension, Pulmonary; Infant; Male; Sulfonamides; Treatment Outcome | 2014 |
Eisenmenger syndrome with unrepaired patent ductus arteriosus.
Topics: Blood Transfusion; Bosentan; Diagnostic Imaging; Dobutamine; Ductus Arteriosus, Patent; Eisenmenger Complex; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Menorrhagia; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Tomography, X-Ray Computed; Vasodilator Agents; Young Adult | 2015 |
Bosentan in pulmonary hypertension secondary to unilateral absence of a pulmonary artery.
Topics: Adult; Angiography; Antihypertensive Agents; Bosentan; Ductus Arteriosus, Patent; Echocardiography; Female; Humans; Hypertension, Pulmonary; Pulmonary Artery; Sulfonamides | 2015 |
Transcatheter intervention following bosentan-iloprost treatment in a patient with patent ductus arteriosus and pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Ductus Arteriosus, Patent; Female; Humans; Hypertension, Pulmonary; Iloprost; Septal Occluder Device; Sulfonamides; Vasodilator Agents | 2012 |
Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension.
Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Ductus Arteriosus, Patent; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Male; Middle Aged; Sulfonamides | 2007 |
Bosentan treatment in an adult with pulmonary hypertension due to patent ductus arteriosus permits surgical repair.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiopulmonary Bypass; Ductus Arteriosus, Patent; Female; Humans; Hypertension, Pulmonary; Sulfonamides | 2007 |